S&P 500
(0.05%) 5 472.24 points
Dow Jones
(0.07%) 39 140 points
Nasdaq
(0.37%) 17 783 points
Oil
(-0.05%) $80.79
Gas
(-3.66%) $2.66
Gold
(-0.79%) $2 312.50
Silver
(0.25%) $28.94
Platinum
(3.61%) $1 022.00
USD/EUR
(0.29%) $0.936
USD/NOK
(0.69%) $10.68
USD/GBP
(0.46%) $0.792
USD/RUB
(-0.27%) $87.25

实时更新: SAB Biotherapeutics, Inc. [SABS]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
最后更新时间26 Jun 2024 @ 22:35

-1.37% $ 2.89

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 22:35):
Our systems believe the stock currently is undervalued by 0.07% compare to its pairs and should correct upwards.
Profile picture for SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases comprising COVID-19 and influenza, immune and autoimmune disorders, such as type 1 diabetes, organ transplantation, and cancer...

Stats
今日成交量 887
平均成交量 15 945
市值 26.67M
EPS $-0.540 ( Q1 | 2024-05-20 )
下一个收益日期 ( $-1.130 ) 2024-08-19
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.430
(Sector) 42.63
(Industry) 24.32
ATR14 $0.0840 (2.90%)
AADI -3.24%
ABCL 1.65%
ABCM 0.04%
ABEO -2.61%
ABIO -3.73%
ABOS 0.70%
ABSI 2.04%
ABUS -1.80%
ABVX -1.50%
ACAD -0.51%
ACER -17.95%
ACET -5.41%
ACGN 1.29%
ACHL -4.11%
ACHV -0.43%
ACIU -0.75%
ACLX 0.74%
ACRV -2.31%
ACST -2.90%
ACXP 1.38%
ADAG 4.64%
ADAP -4.05%
ADGI 0.87%
ADIL 1.75%
ADMA -2.09%
ADPT 0.12%
ADTX -2.37%
ADVM -3.33%
ADXN -1.60%
AEON -4.66%
AEZS -2.49%
AFMD -1.60%
AGEN -2.05%
AGIO -2.42%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA 0.57%
AKRO -3.19%
AKTX -2.28%
AKUS 0.00%
ALBO 0.00%
ALDX -2.10%
ALEC 0.92%
ALGS -0.74%
ALKS 0.37%
ALLK -9.32%
ALLO -6.04%
ALLR -0.63%
ALNA 3.16%
ALNY 2.40%
ALPN 0.02%
ALPX 0.00%
ALRN -1.33%
ALT -9.31%
ALVR 2.60%
ALXN 0.00%
ALXO -13.24%
ALZN 5.27%
AMRN -1.14%
AMTI -3.13%
ANAB 1.45%
ANEB -1.52%
ANGN 0.00%
ANIX -1.62%
ANL -6.60%
ANNX -0.11%
ANPC -3.15%
APGE -0.05%
APGN 8.48%
APGNW 30.65%
APLM -2.32%
APLS 0.07%
APLT -3.04%
APM 0.36%
APOP 0.38%
APRE 0.60%
APTO 5.98%
APTX 3.17%
APVO 0.93%
ARAV -13.39%
ARCT -4.88%
ARDS -14.23%
ARDX 0.17%
ARGX -0.90%
ARNA 0.00%
ARPO -0.90%
ARQT -0.31%
ARTL -2.50%
ARTLW 0.00%
ARVN 5.36%
ARWR -0.67%
ASLN -3.88%
ASMB -5.81%
ASND -1.74%
ATAI -2.22%
ATHA 5.02%
ATHE 0.56%
ATHX -33.50%
ATNF 4.29%
ATOS 1.94%
ATRA -2.08%
ATXI -2.78%
ATXS -0.55%
AUPH -0.90%
AURA 2.79%
AUTL -1.58%
AVBP -1.89%
AVEO 0.00%
AVIR -0.44%
AVRO -1.41%
AVTE -3.45%
AVTX -1.25%
AVXL -3.83%
AXLA 0.00%
AXSM -1.08%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 2.87%
BCAB 5.57%
BCDA -2.23%
BCDAW -41.77%
BCEL 0.00%
BCLI 4.36%
BCRX 0.21%
BCTX 8.90%
BCTXW -16.32%
BCYC 0.95%
BDRX -4.62%
BDTX -1.50%
BEAM 0.93%
BFRA -2.91%
BGNE -2.78%
BIOR -6.15%
BIVI 3.41%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.89%
BLTE -0.78%
BLU 0.03%
BLUE 0.58%
BMEA -10.97%
BMRN 0.05%
BNOX 6.22%
BNTC -0.42%
BNTX -1.65%
BOLD -12.19%
BOLT -0.65%
BPMC -1.14%
BPTH 0.00%
BPTS -13.47%
BRNS 0.00%
BRTX -3.52%
BTAI 25.13%
BTTX 50.67%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 4.24%
CABA 1.66%
CADL -1.95%
CALA 0.00%
CALC -1.77%
CALT -1.59%
CAPR -1.72%
CARA -0.06%
CARM 13.42%
CASI -1.65%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -5.90%
CCCC -6.36%
CCXI 0.00%
CDAK 0.00%
CDIO -2.18%
CDIOW 24.00%
CDMO -2.96%
CDMOP 0.04%
CDT -4.84%
CDTTW -39.60%
CDTX -1.31%
CDXC 0.82%
CDXS 7.60%
CELC -4.21%
CELU -1.00%
CELUW 11.80%
CERC -1.68%
CERE -1.39%
CERO -3.88%
CEROW -21.56%
CFRX -27.95%
CGEM -3.16%
CGEN -3.31%
CGON -1.44%
CGTX -4.55%
CHMA -6.00%
CHRS 1.58%
CINC 0.00%
CING -2.67%
CINGW 34.95%
CKPT -3.81%
CLBS -16.75%
CLDX -1.49%
CLGN 0.34%
CLLS -4.15%
CLNN 0.00%
CLNNW 0.00%
CLRB 6.30%
CLSD -4.00%
CLSN -0.68%
CLVS 0.00%
CMMB -0.98%
CMND 0.00%
CMPI 0.00%
CMPX -1.42%
CMRA 0.00%
CMRAW 33.33%
CMRX -3.47%
CNCE 0.00%
CNSP -36.23%
CNST 0.00%
CNTA -0.28%
CNTB 0.00%
CNTX -7.31%
COCP -2.00%
COEPW 32.45%
COGT -3.49%
CORT 2.73%
COYA -1.46%
CPRX -1.02%
CRBP -3.12%
CRBU -6.52%
CRDF -1.11%
CRGX -0.07%
CRIS -1.72%
CRNX -5.85%
CRSP 0.60%
CRTX 2.63%
CRVO -5.75%
CRVS 1.69%
CSBR -1.59%
CTCX -1.60%
CTIC 0.06%
CTMX -4.13%
CTNM -2.11%
CTXR 2.45%
CUE 6.62%
CVAC -5.36%
CVKD -2.85%
CWBR 2.80%
CYAD -12.96%
CYCC 9.09%
CYCCP 5.49%
CYCN -0.24%
CYT -2.27%
CYTK -2.17%
CYTO -1.82%
DARE 4.02%
DAWN -1.05%
DBTX -0.81%
DBVT 4.17%
DFFN 10.28%
DICE 0.06%
DMAC 28.32%
DNLI -1.38%
DNTH -10.07%
DOMH 2.43%
DRMA -1.68%
DRMAW -1.25%
DRNA 0.00%
DRTS 3.45%
DRTSW 0.00%
DRUG 0.95%
DSGN -2.72%
DTIL 1.99%
DYAI 12.26%
EARS -1.77%
EDIT -2.42%
EDSA 3.19%
EFTR 5.11%
EFTRW -51.85%
EIGR -9.21%
ELAB -2.84%
ELDN 8.99%
ELEV -6.64%
ELOX -5.38%
ELTX -4.26%
ELVN -4.10%
ELYM 2.23%
ENGN -1.72%
ENGNW 0.00%
ENLV 2.90%
ENOB 1.79%
ENSC 3.23%
ENTA 0.08%
ENTO -2.42%
ENTX 1.60%
ENVB 1.58%
EPIX -2.36%
EPRX -1.15%
EPZM 0.00%
EQ 0.34%
EQRX -2.09%
EQRXW 0.00%
ERAS -0.96%
ERNA 0.00%
ERYP 1.30%
ESLA 4.30%
ESLAW 16.64%
ETNB -3.37%
ETON 1.82%
ETTX 0.00%
EVAX -2.14%
EVGN 4.76%
EVLO 0.00%
EWTX -0.37%
EXAI -1.13%
EXEL -0.07%
EYEG -0.69%
EYEN 1.42%
EYPT 0.36%
FATE -9.95%
FBIO 1.06%
FBIOP -0.37%
FBLG -15.40%
FBRX -0.02%
FDMT -3.41%
FENC -1.29%
FGEN -7.30%
FHTX 6.87%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -1.82%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE -0.36%
FULC -3.43%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -5.83%
GANX -2.31%
GBIO -2.83%
GBT 0.01%
GDTC 0.50%
GERN -4.65%
GHRS -2.30%
GLMD -3.85%
GLPG -1.98%
GLSI 1.43%
GLTO -2.16%
GLUE -3.17%
GLYC -10.15%
GMAB -0.50%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -3.14%
GNLX 0.00%
GNPX 1.49%
GNTA 3.94%
GOSS -10.90%
GOVX 1.82%
GOVXW -49.04%
GPCR -8.08%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS 1.48%
GRTX 5.14%
GTHX 0.23%
GUTS -5.08%
GXGXW 41.67%
GYRE -8.82%
HALO -1.28%
HARP 0.09%
HCWB -3.75%
HEPA -4.09%
HGEN -84.62%
HILS 5.66%
HLVX 0.15%
HOOK 2.33%
HOTH -3.51%
HOWL -1.71%
HRMY 1.83%
HRTX 4.10%
HSTO 0.00%
HUMA 0.41%
HUMAW -0.01%
IBRX -4.26%
ICCC 0.22%
ICPT 0.21%
ICU 19.89%
ICUCW 20.46%
ICVX -0.91%
IDRA -23.04%
IDYA -1.58%
IFRX -1.85%
IGMS -0.29%
IKNA 1.19%
IKT 0.70%
IMAB 2.33%
IMCR -3.01%
IMGN 0.02%
IMGO 0.00%
IMMP 3.97%
IMMX -7.76%
IMNM 0.74%
IMNN 0.88%
IMPL -27.27%
IMRA 15.96%
IMRN -1.18%
IMRX 0.00%
IMTX -0.67%
IMTXW 6.00%
IMUX 1.85%
IMV 0.00%
IMVT -4.82%
INAB -0.56%
INBX 1.06%
INCY -1.33%
INDP 11.07%
INFI -52.38%
INKT -0.01%
INM -0.23%
INMB 1.82%
INO -1.31%
INSM -1.46%
INTS -2.75%
INVA 0.53%
INZY 0.69%
IOBT -10.63%
IONS 0.81%
IOVA -2.96%
IPA -0.49%
IPHA 5.58%
IPSC -2.54%
IRON -1.89%
ISEE 0.38%
ITOS -1.71%
ITRM 1.67%
IVA 6.96%
IVVD -3.29%
JAGX 1.19%
JANX -3.84%
JAZZ -0.56%
JNCE 0.00%
JSPR -6.17%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.54%
KALV -5.62%
KDNY 0.22%
KMPH -0.34%
KNSA -2.06%
KNTE -0.38%
KOD -6.17%
KPRX 0.96%
KPTI -5.05%
KRBP -10.00%
KRON 0.58%
KROS -1.10%
KRRO -8.11%
KRTX 0.03%
KRYS -0.41%
KTRA 9.50%
KTTA -6.79%
KTTAW 0.92%
KURA -0.29%
KYMR -3.02%
KYTX -4.46%
KZIA 2.65%
KZR -1.04%
LABP 0.57%
LBPH -1.50%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.73%
LENZ -4.30%
LEXX -0.78%
LEXXW -14.63%
LGND -0.50%
LGNDV 0.00%
LGVN -7.96%
LIAN -8.28%
LIFE 2.70%
LIPO -3.87%
LIXT -5.24%
LIXTW 63.57%
LJPC -0.32%
LMNL 0.12%
LOGC 1.39%
LPCN -1.86%
LPTX -2.75%
LQDA -0.33%
LRMR -1.92%
LSTA -4.06%
LTRN 1.37%
LUMO -1.32%
LVTX -1.03%
LXEO -4.08%
LXRX -2.34%
LYEL -36.27%
LYRA 1.16%
MACK 0.10%
MBIO -10.02%
MBRX -1.72%
MCRB 3.14%
MDGL -1.14%
MDNA -13.16%
MDWD -0.14%
MDXG -2.80%
MEIP 1.40%
MESO -1.26%
MGNX -2.10%
MGTA -7.74%
MGTX -3.61%
MGX -4.02%
MIRM -1.03%
MIRO 0.59%
MIST 1.15%
MITO 0.00%
MLEC -7.69%
MLECW 2.31%
MLND -5.36%
MLTX 0.55%
MLYS -7.37%
MNKD 0.37%
MNMD -0.07%
MNOV 2.11%
MNPR -8.52%
MOLN 1.79%
MOR 1.20%
MORF -3.22%
MREO -2.71%
MRKR 2.57%
MRNA -6.07%
MRNS -4.04%
MRSN -2.38%
MRTX -0.17%
MRUS 0.16%
MRVI -1.16%
MTCR -1.29%
MTEM 4.46%
MTP -18.50%
MURA -0.93%
MYMD 5.75%
NAMS 3.33%
NAMSW -0.21%
NAUT 1.55%
NBRV 0.71%
NBSE -1.56%
NBTX 12.09%
NCNA 0.73%
NERV -0.63%
NEXI 4.04%
NGM -1.28%
NGNE -1.41%
NKGN 10.08%
NKGNW 8.00%
NKTR -4.21%
NKTX -5.30%
NLSP 5.88%
NLSPW 26.67%
NMRA -3.08%
NMTR -42.97%
NOVN -24.84%
NRBO 7.29%
NRIX -2.26%
NRSN -5.12%
NRSNW 0.00%
NRXP -3.72%
NRXPW 18.33%
NRXS 4.82%
NTBL 3.42%
NTEC -12.45%
NTHI 0.00%
NTLA -6.73%
NTRBW -31.07%
NUVL -1.67%
NVAX -2.29%
NVCT 3.55%
NVIV -34.28%
NXTC -2.94%
NYMX -0.05%
OABI 1.32%
OABIW -10.06%
OBIO -3.07%
OBSV 0.00%
OCEA 0.00%
OCGN 2.54%
OCS -1.00%
OCUL -0.08%
OCUP 1.84%
ODT -4.27%
OKYO 1.51%
OLMA -5.29%
OMER -1.03%
OMGA 5.63%
ONCO 4.54%
ONCR -3.08%
ONCS 31.87%
ONCT -3.05%
ONCY 1.38%
ONTX -0.47%
ONVO 0.47%
OPNT 0.00%
OPT 3.09%
ORGS 0.96%
ORIC -3.41%
ORMP 18.30%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -2.22%
OVID 0.51%
OYST 0.00%
PALI 1.30%
PASG -1.30%
PBLA -7.50%
PBM -3.48%
PBYI 1.18%
PCSA 0.00%
PCVX -0.25%
PDSB -3.16%
PEPG 1.38%
PGEN -2.70%
PHAR 1.51%
PHAS 0.00%
PHAT -1.06%
PHIO -3.57%
PHIOW 36.47%
PHVS -7.32%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -1.33%
PLUR 7.39%
PMN 0.72%
PMVP -0.59%
PNT 0.16%
PPBT -5.53%
PRAX 2.81%
PRDS 0.93%
PRLD -2.37%
PROG -3.47%
PROK 0.00%
PRQR -0.66%
PRTA -2.46%
PRTC 0.49%
PRTG 7.02%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -10.46%
PSTX -1.36%
PTCT -0.37%
PTE -0.82%
PTGX -0.87%
PTIXW -48.41%
PULM 2.60%
PXMD 4.76%
PYPD 0.07%
PYXS 0.65%
QLGN -3.00%
QNCX 5.70%
QNRX -1.14%
QSI -11.54%
QSIAW -3.13%
QTTB -3.45%
QURE -0.78%
RAIN -1.63%
RANI 6.42%
RAPT -1.30%
RARE 1.58%
RCKT -8.79%
REGN 0.23%
RENB -3.12%
REPL -2.49%
RETA 0.02%
REUN -0.89%
REVB -2.79%
REVBU 3.46%
REVBW 4.38%
RGLS -6.78%
RGNX -6.00%
RIGL -3.28%
RLAY -3.86%
RLMD 0.35%
RLYB -1.34%
RNA 0.67%
RNAC -2.94%
RNAZ -1.90%
RNXT 0.89%
ROIV -2.08%
ROIVW 4.56%
RPHM -0.93%
RPRX 0.24%
RPTX 0.15%
RUBY 2.70%
RVLP -32.05%
RVMD -1.16%
RVMDW -30.00%
RVNC 0.21%
RVPH -1.98%
RVPHW 1.62%
RXDX 0.09%
RXRX -4.10%
RYTM -5.88%
RYZB 0.02%
RZLT 3.88%
SABS -1.37%
SABSW -11.81%
SAGE 1.38%
SANA -3.87%
SAVA -0.16%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI -0.06%
SCPH 4.80%
SCPS 0.00%
SEEL -4.03%
SEER 0.29%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -1.31%
SGMT -2.42%
SGTX -2.56%
SIOX 22.63%
SLDB -8.97%
SLGL 4.12%
SLN -4.57%
SLNO -4.49%
SLRX 5.27%
SLS -1.71%
SMMT -1.62%
SNDX 1.13%
SNGX -4.91%
SNPX -4.44%
SONN 0.00%
SPPI -0.49%
SPRB 0.63%
SPRC -2.75%
SPRO 0.05%
SRNE -34.00%
SRPT -1.11%
SRRA 0.00%
SRRK -2.35%
SRZN -2.45%
STAB 0.00%
STOK -5.52%
STRO -3.67%
STSA 0.00%
STTK -1.69%
SURF -0.93%
SVRA -7.93%
SWTX -0.41%
SYBX -1.29%
SYRS -1.55%
TALS -0.73%
TARA -7.62%
TARS 0.08%
TBPH 0.72%
TCBP 2.48%
TCDA 0.00%
TCON 2.46%
TCRR 0.00%
TCRT 0.08%
TCRX -1.45%
TECH -0.21%
TENX 1.91%
TERN -8.53%
TFFP -5.33%
TGTX -4.46%
THRX 0.12%
TIL -1.09%
TLC 0.00%
TLSA -4.60%
TNGX -3.67%
TNXP -6.37%
TNYA -4.73%
TPST 4.84%
TRDA -4.06%
TRVI 2.30%
TRVN 1.60%
TSHA -22.87%
TSVT -3.32%
TTNP -7.66%
TVTX 1.51%
TYRA -8.54%
UBX -2.83%
UNCY -4.00%
URGN -1.15%
UTHR 0.57%
VACC 11.36%
VALN -4.07%
VAXX 114.20%
VBIV 0.33%
VBLT -8.77%
VCEL 0.96%
VCNX 10.35%
VCYT -1.59%
VERA -4.20%
VERU 0.97%
VERV -2.96%
VIGL 4.84%
VINC 2.28%
VIR 0.98%
VIRI -1.73%
VIRX 3.15%
VKTX -1.42%
VLON -13.04%
VNDA -3.52%
VOR -1.61%
VRCA 0.00%
VRDN -4.54%
VRNA -0.66%
VRPX 0.38%
VRTX 0.30%
VSTM -0.85%
VTGN -1.79%
VTVT -2.97%
VTYX -1.46%
VXRT -5.09%
VYGR -0.26%
VYNE -4.62%
VYNT 7.78%
WINT 2.18%
WVE -6.29%
XBIO 1.03%
XBIT -0.84%
XCUR 3.55%
XENE -1.51%
XERS 2.38%
XFOR 4.15%
XLO 3.94%
XLRN 0.00%
XNCR 0.52%
XOMA -3.34%
XOMAO -0.16%
XOMAP -0.82%
XRTX -8.00%
YMAB -1.67%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -2.59%
ZNTL -2.15%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-04 Conley Mark William Sell 25 000 Employee Stock Option (right to buy)
2024-05-03 Skyler Jay S Buy 0
2024-02-21 Kropotova Alexandra Buy 140 000 Employee Stock Option (right to buy)
2024-02-21 Sullivan Eddie Joe Buy 190 000 Employee Stock Option (right to buy)
2024-02-21 Bausch Christoph Lawrence Buy 140 000 Employee Stock Option (right to buy)
INSIDER POWER
69.75
Last 87 transactions
Buy: 19 533 010 | Sell: 3 162 658
相关性 (AI algo v.1.1b): Undervalued: 0.07% $2.90 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

SAB Biotherapeutics, Inc. 相关性

10 最正相关
GPRO0.913
GP0.908
PETS0.907
SSTI0.906
PRTS0.906
MKTW0.905
APPS0.904
AUUD0.901
TBLT0.901
AGRX0.899
10 最负相关
APXI-0.92
ACGL-0.905
SWAV-0.905
TCOM-0.903
GHRS-0.902
DXJS-0.901
HYAC-0.898
AEAE-0.897
IBKR-0.896
COOP-0.89

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

SAB Biotherapeutics, Inc. 财务报表

Annual 2023
营收: $2.24M
毛利润: $-1.51M (-67.28 %)
EPS: $-7.64
FY 2023
营收: $2.24M
毛利润: $-1.51M (-67.28 %)
EPS: $-7.64
FY 2022
营收: $23.90M
毛利润: $20.61M (86.23 %)
EPS: $-4.31
FY 2021
营收: $60.88M
毛利润: $0.00 (0.00 %)
EPS: $-0.394

Financial Reports:

No articles found.

SAB Biotherapeutics, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases comprising COVID-19 and influenza, immune and autoimmune disorders, such as type 1 diabetes, organ transplantation, and cancer. The company uses its DiversitAb immunotherapy platform to produce fully-human polyclonal antibodies without the need for human donors. Its lead product candidates include SAB-185, a fully-human polyclonal antibody therapeutic candidate that is in Phase III clinical trial for the treatment of COVID-19; and SAB-176, a fully-human polyclonal antibody therapeutic candidate that is in development to treat or prevent severe influenza. The company's pre-clinical product candidates in development for autoimmune diseases include SAB-142 for type 1 diabetes and organ transplant induction/rejection. The company was founded in 2014 and is based in Sioux Falls, South Dakota.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。

Total Execution Time: 1.3468599319458 seconds
Number of API calls: 3
Number of DB calls: 9